Pyrine or pyrazine derivatives for treating hcv

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 405/02 (2006.01) A61K 31/4427 (2006.01) A61K 31/5377 (2006.01) A61P 31/14 (2006.01) C07D 401/02 (2006.01) C07D 401/14 (2006.01) C07D 405/14 (2006.01) C07D 413/14 (2006.01)

Patent

CA 2736472

Compounds having the formula I wherein R1, R2a, R2b, R2c, R3, Y and p are as defined herein and C2-C3 is a single or double bond are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.

Linvention concerne des composés de formule I, dans laquelle R1, R2a, R2b, R2c, R3, Y et p sont tels que définis dans le présent document et C2-C3 est une simple ou double liaison, qui sont des inhibiteurs de NS5b polymérase du virus de lhépatite C. Linvention concerne également des compositions et des procédés de traitement dune infection par le VHC et dinhibition de la réplication du VHC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrine or pyrazine derivatives for treating hcv does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrine or pyrazine derivatives for treating hcv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrine or pyrazine derivatives for treating hcv will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1840048

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.